Skip to content

Follow-Up Study of Patients Previously Treated With Pimecrolimus Tablets for Atopic Dermatitis

A Follow-Up Study of Patients Previously Treated in a Core Study With Pimecrolimus Tablets for Atopic Dermatitis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00098150
Enrollment
66
Registered
2004-12-06
Start date
2004-07-31
Completion date
Unknown
Last updated
2006-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic Dermatitis

Keywords

Safety, atopic dermatitis, adverse event, SAE, extension

Brief summary

This extension study is being conducted to collect post-treatment safety information on patients who previously participated in the core clinical trial.

Interventions

None listed

Sponsors

Novartis
Lead SponsorINDUSTRY

Study design

Observational model
DEFINED_POPULATION
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Consenting patients who participated in the core clinical trial

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026